B2Gold Corp. (0QYN)
London Exchange · UK · prices in CAD · close of 21 Oct 2026
Key indicators
| Last close | CAD 7.340 |
|---|---|
| 52-week range | 5.022 – 8.494 |
| Return, 1 month / 3 months | −1.3% / +42.8% |
| Return, 1 year / 3 years | +6.0% / +102.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 49 |
| Volatility (1 year) | 59.7% |
| Worst drawdown (1 year) | -39.0% |
| Average daily value traded | 0.80M CAD |
| Dividend yield | 1.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
B2Gold Corp. is a gold mining company based in Vancouver, Canada. It explores for, develops and operates gold mines in several countries, including Mali, Namibia and the Philippines, and produces gold in the form of doré bars and concentrate. Its customers are gold refiners and metal traders who process and distribute the metal into global markets. The company manages open-pit and underground mining operations and also carries out exploration work around its existing mines and at earlier-stage projects.
B2Gold Corp. trades under the code 0QYN on the London Exchange in UK, with its price quoted in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
B2Gold Corp. (0QYN) trades on the London Exchange in UK. It last closed at CAD 7.340 on 21 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 1,579 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 6.0% and over the last three months it rose 42.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 73 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 10.7% | ||
| From 52-week high | -12.0% | ||
| Momentum | 72 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 42.8% | ||
| 6-month return | 8.9% | ||
| 12-month return, skipping the last month | 7.5% | ||
| Stability (higher is calmer) | 26 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 59.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -39.0% | ||
| Liquidity | 50 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.80M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 69 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.5% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +4.0% |
|---|---|
| 1 month | −1.3% |
| 3 months | +42.8% |
| 6 months | +8.9% |
| 1 year | +6.0% |
| 3 years | +102.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 7.445 / 6.630 |
|---|---|
| Golden / death cross (60 days) | Golden, 24 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.213 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Sep 2026 | CAD 0.0276 |
| 9 Jun 2026 | CAD 0.0279 |
| 6 Mar 2026 | CAD 0.0273 |
| 2 Dec 2025 | CAD 0.0280 |
| 10 Sep 2025 | CAD 0.0277 |
| 10 Jun 2025 | CAD 0.0274 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.